Literature DB >> 21853361

Behavior of monoclonal antibodies: relation between the second virial coefficient (B (2)) at low concentrations and aggregation propensity and viscosity at high concentrations.

Shuntaro Saito1, Jun Hasegawa, Naoki Kobayashi, Naoyuki Kishi, Susumu Uchiyama, Kiichi Fukui.   

Abstract

PURPOSE: To investigate relationship between second virial coefficient B (2) and viscosity and aggregation propensity of highly concentrated monoclonal antibody (MAbs) solutions.
METHODS: Intermolecular interactions of 3 MAbs solutions with varying pH were characterized according to B (2) estimated by analytical ultracentrifugation sedimentation equilibrium with initial loading concentrations <10 mg/mL. Viscosity measurements and stability assessments of MAb solutions at concentrations higher than 100 mg/mL were conducted.
RESULTS: B (2) of all MAb solutions depended on solution pH and have qualitative correlation with viscosity and aggregation propensity. The more negative the B (2) values, the more viscous the solution, acquiring increased propensity to aggregate. Solutions with B (2) values of ~2 × 10(-5) mL·mol/g(2) acquire similar viscosity and aggregation propensity regardless of amino acid sequences; for solutions with negative B (2) values, viscosity and aggregation propensity differed depending on sequences. Results suggest attractive intermolecular interactions represented by negative B (2) values are influenced by surface properties of individual MAbs.
CONCLUSIONS: B (2) can be used, within certain limitations, as an effective indicator of viscosity and aggregation propensity of highly concentrated MAb solutions.

Mesh:

Substances:

Year:  2011        PMID: 21853361     DOI: 10.1007/s11095-011-0563-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  37 in total

1.  Inverse relationship of protein concentration and aggregation.

Authors:  Michael J Treuheit; Andrew A Kosky; David N Brems
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

2.  Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor.

Authors:  Eva Y Chi; Sampathkumar Krishnan; Brent S Kendrick; Byeong S Chang; John F Carpenter; Theodore W Randolph
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

3.  Protein interactions in undersaturated and supersaturated solutions: a study using light and x-ray scattering.

Authors:  Janaky Narayanan; X Y Liu
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

4.  A critical evaluation of self-interaction chromatography as a predictive tool for the assessment of protein-protein interactions in protein formulation development: a case study of a therapeutic monoclonal antibody.

Authors:  Virginie Le Brun; Wolfgang Friess; Stefan Bassarab; Silke Mühlau; Patrick Garidel
Journal:  Eur J Pharm Biopharm       Date:  2010-01-25       Impact factor: 5.571

5.  Molecular origins of osmotic second virial coefficients of proteins.

Authors:  B L Neal; D Asthagiri; A M Lenhoff
Journal:  Biophys J       Date:  1998-11       Impact factor: 4.033

6.  Structure-based engineering of a monoclonal antibody for improved solubility.

Authors:  Sheng-Jiun Wu; Jinquan Luo; Karyn T O'Neil; James Kang; Eilyn R Lacy; Gabriela Canziani; Audrey Baker; Maggie Huang; Qing Mike Tang; T Shantha Raju; Steven A Jacobs; Alexey Teplyakov; Gary L Gilliland; Yiqing Feng
Journal:  Protein Eng Des Sel       Date:  2010-06-11       Impact factor: 1.650

7.  Ion-specific modulation of protein interactions: anion-induced, reversible oligomerization of a fusion protein.

Authors:  Yatin R Gokarn; R Matthew Fesinmeyer; Atul Saluja; Shawn Cao; Jane Dankberg; Andrew Goetze; Richard L Remmele; Linda O Narhi; David N Brems
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

8.  Understanding and modulating opalescence and viscosity in a monoclonal antibody formulation.

Authors:  Branden A Salinas; Hasige A Sathish; Steven M Bishop; Nick Harn; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2010-01       Impact factor: 3.534

9.  Long- and short-range electrostatic interactions affect the rheology of highly concentrated antibody solutions.

Authors:  Ravi Chari; Kavita Jerath; Advait V Badkar; Devendra S Kalonia
Journal:  Pharm Res       Date:  2009-10-01       Impact factor: 4.200

10.  Nonequivalence of second virial coefficients from sedimentation equilibrium and static light scattering studies of protein solutions.

Authors:  Donald J Winzor; Marcin Deszczynski; Stephen E Harding; Peter R Wills
Journal:  Biophys Chem       Date:  2007-03-07       Impact factor: 2.352

View more
  30 in total

1.  Viscosity Analysis of Dual Variable Domain Immunoglobulin Protein Solutions: Role of Size, Electroviscous Effect and Protein-Protein Interactions.

Authors:  Ashlesha S Raut; Devendra S Kalonia
Journal:  Pharm Res       Date:  2015-08-19       Impact factor: 4.200

Review 2.  Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development.

Authors:  Dheeraj S Tomar; Sandeep Kumar; Satish K Singh; Sumit Goswami; Li Li
Journal:  MAbs       Date:  2016-01-06       Impact factor: 5.857

3.  High throughput detection of antibody self-interaction by bio-layer interferometry.

Authors:  Tingwan Sun; Felicia Reid; Yuqi Liu; Yuan Cao; Patricia Estep; Claire Nauman; Yingda Xu
Journal:  MAbs       Date:  2013-08-19       Impact factor: 5.857

4.  Quantitative Correlation between Viscosity of Concentrated MAb Solutions and Particle Size Parameters Obtained from Small-Angle X-ray Scattering.

Authors:  Masakazu Fukuda; Chifumi Moriyama; Tadao Yamazaki; Yoshimi Imaeda; Akiko Koga
Journal:  Pharm Res       Date:  2015-06-16       Impact factor: 4.200

5.  A novel screening method to assess developability of antibody-like molecules.

Authors:  Neeraj Kohli; Nidhi Jain; Melissa L Geddie; Maja Razlog; Lihui Xu; Alexey A Lugovskoy
Journal:  MAbs       Date:  2015       Impact factor: 5.857

6.  Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.

Authors:  Pilarin Nichols; Li Li; Sandeep Kumar; Patrick M Buck; Satish K Singh; Sumit Goswami; Bryan Balthazor; Tami R Conley; David Sek; Martin J Allen
Journal:  MAbs       Date:  2015       Impact factor: 5.857

7.  Intermolecular Interactions and the Viscosity of Highly Concentrated Monoclonal Antibody Solutions.

Authors:  Elaheh Binabaji; Junfen Ma; Andrew L Zydney
Journal:  Pharm Res       Date:  2015-04-02       Impact factor: 4.200

8.  Challenges in Predicting Protein-Protein Interactions from Measurements of Molecular Diffusivity.

Authors:  Lea L Sorret; Madison A DeWinter; Daniel K Schwartz; Theodore W Randolph
Journal:  Biophys J       Date:  2016-11-01       Impact factor: 4.033

9.  Isotonic concentrations of excipients control the dimerization rate of a therapeutic immunoglobulin G1 antibody during refrigerated storage based on their rank order of native-state interaction.

Authors:  Douglas D Banks; Jon F Cordia; Vladimir Spasojevic; Jeonghoon Sun; Sarah Franc; Younhee Cho
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

10.  Weak interactions govern the viscosity of concentrated antibody solutions: high-throughput analysis using the diffusion interaction parameter.

Authors:  Brian D Connolly; Chris Petry; Sandeep Yadav; Barthélemy Demeule; Natalie Ciaccio; Jamie M R Moore; Steven J Shire; Yatin R Gokarn
Journal:  Biophys J       Date:  2012-07-03       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.